Menu
Back to User profile » Professor Gerard J Criner
Papers published by Professor Gerard J Criner:
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial
Gabrio A, Gunsoy NB, Baio G, Martin A, Paly VF, Risebrough N, Halpin DMG, Singh D, Wise RA, Han MK, Martinez FJ, Criner GJ, Martin N, Lipson DA, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1633-1642
Published Date: 25 July 2022
The Impact of Budesonide/Formoterol pMDI Medication Reminders on Adherence in Chronic Obstructive Pulmonary Disease (COPD) Patients: Results of a Randomized, Phase 4, Clinical Study
Criner GJ, Cole T, Hahn KA, Kastango K, Eudicone J, Gilbert I
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:563-577
Published Date: 4 March 2021
Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the Spiromics Cohort
Cooper CB, Paine R, Curtis JL, Kanner RE, Martinez CH, Meldrum CA, Bowler R, O'Neal W, Hoffman EA, Couper D, Quibrera M, Criner G, Dransfield MT, Han MK, Hansel NN, Krishnan JA, Lazarus SC, Peters SP, Barr RG, Martinez FJ, Woodruff PG
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1887-1898
Published Date: 4 August 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]
Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine III R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, Hansel N, Wells JM, Ortega VE, Hoffman EA, Doerschuk CM, Kim V, Dransfield MT, Drummond MB, Bowler R, Criner G, Christenson SA, Ronish B, Peters SP, Krishnan JA, Tashkin DP, Cooper CB
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:901-902
Published Date: 23 April 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine III R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, Hansel N, Wells JM, Ortega VE, Hoffman EA, Doerschuk CM, Kim V, Dransfield MT, Drummond MB, Bowler R, Criner G, Christenson SA, Ronish B, Peters SP, Krishnan JA, Tashkin DP, Cooper CB
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2927-2938
Published Date: 20 December 2019
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
Ismaila AS, Risebrough N, Schroeder M, Shah D, Martin A, Goodall EC, Ndirangu K, Criner G, Dransfield M, Halpin DMG, Han MK, Lomas DA
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2681-2695
Published Date: 29 November 2019
Spotlight on glycopyrronium/formoterol fumarate inhalation aerosol in the management of COPD: design, development, and place in therapy
Dhungana S, Criner GJ
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2307-2312
Published Date: 3 August 2017
Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease
Geiger-Brown J, Lindberg S, Krachman S, McEvoy CE, Criner GJ, Connett JE, Albert RK, Scharf SM
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:389-397
Published Date: 20 February 2015
Total lung capacity by plethysmography and high-resolution computed tomography in COPD
Garfield JL, Marchetti N, Gaughan JP, Steiner RM, Criner GJ
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:119-126
Published Date: 22 February 2012